Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
| Autor: | van Vollenhoven, Ronald F, Hahn, Bevra H, Tsokos, George C, Wagner, Carrie L, Lipsky, Peter, Touma, Zahi, Werth, Victoria P, Gordon, Robert M, Zhou, Bei, Hsu, Benjamin, Chevrier, Marc, Triebel, Manon, Jordan, Jarrat L, Rose, Shawn |
|---|---|
| Zdroj: | In The Lancet 13-19 October 2018 392(10155):1330-1339 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|